ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661748 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661748; 2) Community: the network communities that were significantly associated with the response to NSC 661748; 3) Molecule: the relationships between components within communities and NSC 661748; 4) MDR: the compounds that were significantly associated with the NSC 661748.

NSC Compound Enrichment Correlation
NSC 753393 3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0407060322613564 -0.033778298
NSC 755424 Null 0.0407060322613564 0.010650446
NSC 756193 GSK978744A 0.0407060322613564 0.32801318
NSC 759857 Clofarabine (USAN) 0.0407060322613564 -0.22583219
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0407060322613564 -0.1916279
NSC 762542 Null 0.0407060322613564 0.08146074
NSC 7801 Aniline violet (component of) 0.0407060322613564 0.058193506
NSC 83459 Indole-2,3-dione, 3-(4,4-dimethyl-3-thiosemicarbazone) 0.0407060322613564 -0.28222424
NSC 9612 Benzo[a]phenazoxonium, 5-(benzylamino)-9-(diethylamino)-, chloride (8CI) 0.0407060322613564 -0.1003997
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.0462077035966078 -0.19855665
Total:38  Current:35    [First] [Prev] [Next] [Last]